4
Changes in Ownership
Alto Neuroscience, Inc. Filed Acc 0002009130-26-000004
PRESIDENT AND CFO sold 134,886 shares at an average $26.45 ($3,567,247)
- PRESIDENT AND CFO acquired 134,886 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Smith Nicholas Conrad · PRESIDENT AND CFO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-29 | Exercise or conversion : show line 1 in the form | +56,455 | $2.35 | $132,669 | 80,515 | D |
| 2026-09-29 | Exercise or conversion : show line 2 in the form | +54,375 | $2.35 | $127,781 | 134,890 | D |
| 2026-09-29 | Sale : show line 3 in the form | −110,830 | $26.58 | $2,946,150 | 24,060 | D |
| 2026-09-30 | Exercise or conversion : show line 4 in the form | +24,056 | $2.35 | $56,532 | 48,116 | D |
| 2026-09-30 | Sale : show line 5 in the form | −23,170 | $25.78 | $597,290 | 24,946 | D |
| 2026-09-30 | Sale : show line 6 in the form | −886 | $26.87 | $23,807 | 24,060 | D |
| Open-market sales · 134,886 sh · avg $26.45 · $3,567,247 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-29 | Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) | −56,455 | 145,874 | D |
| 2026-09-29 | Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) | −54,375 | 35,625 | D |
| 2026-09-30 | Exercise or conversion : show line 9 in the form Employee Stock Option (Right to Buy) | −24,056 | 121,818 | D |
Loading xslF345X06/wk-form4_1790904813.xml…